Psychometric Schizotypy Predicts Psychotic-like, Paranoid, and Negative Symptoms in Daily Life by Kwapil, Thomas R. & NC DOCKS at The University of North Carolina at Greensboro
Psychometric Schizotypy Predicts Psychotic-like, Paranoid, and Negative Symptoms in 
Daily Life 
By: Neus Barrantes-Vidal, Charlotte A. Chun, Inez Myin-Germeys, Thomas R. Kwapil 
Barrantes-Vidal, N., Chun, C., Myin-Germeys, I., & Kwapil, T.R. (2013). Psychometric 
schizotypy predicts the experience of psychotic-like, paranoid, and negative symptom 
experiences in daily life. Journal of Abnormal Psychology, 122(4), 1077-87.doi: 
10.1037/a0034793 
Made available courtesy of the American Psychological Association: 
http://www.dx.doi.org/10.1037/a0034793  
 
This article may not exactly replicate the final version published in the APA journal. It is 
not the copy of record. 
 
***© American Psychological Association. Reprinted with permission. No further 
reproduction is authorized without written permission from the American Psychological 
Association. This version of the document is not the version of record. Figures and/or 
pictures may be missing from this format of the document. *** 
Abstract: 
Positive and negative schizotypy exhibit differential patterns of impairment in social relations, 
affect, and functioning in daily life. However, studies have not examined the association of 
schizotypy with real-world expression of psychotic-like, paranoid, and negative symptoms. The 
present study employed experience-sampling methodology (ESM) to assess positive and 
negative schizotypy in daily life in a nonclinical sample of 206 Spanish young adults. 
Participants were prompted randomly 8 times daily for 1 week to complete assessments of their 
current symptoms and experiences. Positive schizotypy was associated with psychotic-like and 
paranoid symptoms in daily life. Negative schizotypy was associated with a subset of these 
symptoms and with negative symptoms in daily life. Momentary stress was associated with 
psychotic-like and paranoid symptoms, but only for those high in positive schizotypy. Social 
stress predicted momentary psychotic-like symptoms in both positive and negative schizotypy. 
Time-lagged analyses indicated that stress at the preceding signal predicted psychotic-like 
symptoms at the current assessment, but only for individuals high in positive schizotypy. The 
results are consistent with models linking stress sensitivity with the experience of psychotic 
symptoms. The findings provide cross-cultural support for the multidimensional model of 
schizotypy and schizophrenia. Furthermore, the findings demonstrate that ESM is an effective 
method for predicting the experience of psychotic-like symptoms, as well as their precursors, in 
daily life. 
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Article: 
Converging evidence indicates that the underlying developmental vulnerability for schizophrenia 
and spectrum disorders is expressed across a dynamic continuum referred to as schizotypy, 
which ranges from subclinical to clinical manifestations (e.g., Claridge et al., 1996; Kwapil & 
Barrantes-Vidal, 2012; Lenzenweger, 2010; Meehl, 1990). Nonpsychotic schizotypes experience 
similar, although attenuated, forms of the cognitive, emotional, and behavioral disturbances 
inherent in schizophrenia, and are at heightened risk for developing schizophrenia-spectrum 
disorders. Thus, schizophrenia is conceptualized as the most extreme manifestation of the 
schizotypy continuum. Schizotypy provides a useful construct for studying the development of 
schizophrenia-spectrum psychopathology, including identification of risk and protective factors 
and intermediate phenotypes. 
Schizotypy, and by extension schizophrenia, is a multidimensional construct ( Raine et al., 
1994; Stefanis et al., 2004; Vollema & van den Bosch, 1995) with positive and negative 
schizotypy the most consistently replicated factors ( Kwapil, Barrantes-Vidal, & Silvia, 2008). 
Positive schizotypy is characterized by unusual perceptual experiences and odd beliefs, whereas 
negative schizotypy is characterized by affective flattening, anhedonia, social disinterest, and 
cognitive impairment. The conceptualization of schizotypy as a multidimensional construct is 
essential for resolving the marked heterogeneity in etiology, presentation, and treatment response 
characteristic of the schizophrenia spectrum ( Kwapil & Barrantes-Vidal, 2012). 
Recent confirmatory factor-analytic studies (e.g., Lewandowski et al., 2006; Brown, Silvia, 
Myin-Germeys, Lewandowski, & Kwapil, 2008; Kwapil et al., 2008) demonstrated that the 
positive and negative schizotypy dimensions can be assessed using the Wisconsin Schizotypy 
scales (WSS), including the Perceptual Aberration ( Chapman, Chapman, & Raulin, 1978), 
Magical Ideation ( Eckblad & Chapman, 1983), Physical Anhedonia ( Chapman, Chapman, & 
Raulin, 1976), and Revised Social Anhedonia ( Eckblad, Chapman, Chapman, & Mishlove, 
1982) Scales. This two-factor structure is consistent across samples and demonstrates cross-
cultural invariance (e.g., Kwapil, Ros-Morente, Silvia, & Barrantes-Vidal, 2012). The positive 
and negative schizotypy dimensions are associated with differential patterns of symptoms and 
impairment in cross-sectional questionnaire studies (e.g., Barrantes-Vidal, Gómez-de-Regil et 
al., 2013; Brown et al., 2008), interview studies (e.g., Barrantes-Vidal, Ros-Morente, & Kwapil, 
2009), and laboratory studies (e.g., Kaczorowski, Barrantes-Vidal, & Kwapil, 2009), as well as 
in prospective interview studies (e.g., Kwapil, Gross, Silvia, & Barrantes-Vidal, 2013). 
Furthermore, these results have been supported in a cross-cultural validation study ( Barrantes-
Vidal, Gross et al., 2013) using Spanish-language versions of the WSS. Specifically, positive 
schizotypy is associated with the development of psychotic and prodromal conditions; psychotic-
like, schizotypal, and paranoid symptoms; mood disorders; substance abuse; and impairment. 
Negative schizotypy is associated with development of schizophrenia-spectrum disorders, 
schizotypal, schizoid, and negative symptoms, social dysfunction, and impaired functioning. 
Experience-Sampling Methodology (ESM) 
Researchers have increasingly employed ESM to examine the experience and expression of 
psychological constructs in daily life (e.g., Mehl & Conner, 2012; Oorschot, Kwapil, Delespaul, 
& Myin-Germeys, 2009). ESM is a within-day self-assessment technique that prompts 
participants at random intervals to complete brief questionnaires about their current experiences, 
including cognition, affect, social functioning, and symptoms. ESM offers several advantages to 
traditional assessment procedures (e.g., DeVries, Delespaul, & Dijkman-Caes, 1992; Hektner, 
Schmidt, & Csikszentmihalyi, 2007). Specifically, ESM (a) repeatedly assesses participants in 
their daily environment, thereby enhancing ecological validity, (b) assesses participants’ 
experiences at the time of the signal, thereby minimizing retrospective bias, and (c) examines the 
context of participants’ experiences. ESM measures exhibit good psychometric properties and 
provide a useful method for studying psychological phenomena outside the traditional (and 
artificial) laboratory and clinical settings ( Csikszentmihalyi & Larson, 1992). 
ESM has been used to assess daily life experiences of schizophrenia-spectrum (e.g., Ben-Zeev, 
Morris, Swendsen, & Granholm, 2012; Kimhy et al., 2010; Myin-Germeys, Nicolson, & 
Delespaul, 2001) and prodromal ( Palmier-Claus, Dunn, & Lewis, 2012) patients. However, few 
studies have examined the real-world expression of nondisordered schizotypy. Vérdoux, Husky, 
Tournier, Sorbara, and Swendson (2003) investigated daily life experiences of individuals with 
subclinical psychotic symptoms and reported positive associations between unusual perceptions 
and contact with unfamiliar people. Collip et al. (2011) found that individuals with paranoid 
traits experienced momentary paranoia and social threats in daily life, regardless of familiarity of 
social contacts. Husky, Grondin, and Swendson (2004) reported that psychosis proneness 
predicted the interaction of mood with social context and environmental situation. In addition, 
socially anhedonic individuals exhibit schizoid-like social functioning in daily life ( Kwapil et 
al., 2009). 
Kwapil, Brown, Silvia, Myin-Germeys, and Barrantes-Vidal (2012) used ESM to examine the 
expression of positive and negative schizotypy dimensions derived from the WSS in 412 young 
adults. Positive schizotypy was associated with increased negative affect, thought impairment, 
suspiciousness, negative beliefs about current activities, and perceived rejection. Negative 
schizotypy, on the other hand, was associated with diminished positive affect and pleasure in 
daily life, and decreases in social contact and interest. However, their study did not assess 
schizotypic symptoms (e.g., psychotic-like, paranoid, and negative symptoms) in daily life. 
Stress, Psychosis, and Daily Life 
Daily life stressors may play an important role in the expression of psychotic-like and paranoid 
symptoms (e.g., van Winkel et al., 2008). Although prolonged or excessive stress can be 
deleterious to anyone, schizotypic individuals may be especially sensitive to the momentary 
effects of stress. ESM studies indicate that both patients with psychosis and their first-degree 
relatives react more intensely to stress in daily life ( Myin-Germeys, van Os, Schwartz, Stone, & 
Delespaul, 2001). This is independent of cognitive impairment, which suggests two distinct 
vulnerability mechanisms: a psychosis-prone/stress-sensitivity pathway (consistent with positive 
schizotypy) and a negative-symptom/neurocognitive-impairment pathway ( Myin-Germeys, 
Krabbendam, Jolles, Delespaul, & van Os, 2002). The finding that positive schizotypy in 
nonpatients is associated with psychotic-like experiences in daily life and that this relationship is 
exacerbated by momentary stress would lend further support for the stress-sensitivity model and 
further validation for the multidimensional model of schizotypy. 
Goals and Hypotheses 
The goal of the present study was to examine the validity of positive and negative schizotypy 
dimensions in a nonclinically ascertained sample of Spanish young adults. Specifically the study 
sought to (a) replicate the differential findings for positive and negative schizotypy reported 
by Kwapil, Brown et al. (2012); (b) extend these findings by examining the association of the 
schizotypy dimensions with ESM measures of psychotic-like, paranoid, and negative symptoms 
in daily life; (c) examine whether stress predicts psychotic-like and paranoid symptoms in high-
positive schizotypy participants; and (d) demonstrate the cross-cultural validity of the schizotypy 
dimensions in a Spanish sample. Based upon our theoretical conceptualization and recent 
interview and ESM studies of schizotypy, we hypothesized that positive and negative schizotypy 
would be associated with differential patterns of experiences in daily life. Specifically, we 
expected that positive schizotypy would be associated with increased negative affect, elevated 
ratings of stressful situations, paranoid and psychotic-like symptoms, feeling unwanted, and 
feeling unable to cope. Negative schizotypy was predicted to be associated with diminished 
positive affect, reports of negative symptoms (no thoughts or emotions), solitude, and diminished 
social closeness. 
Consistent with Myin-Germeys et al.’s (2002) stress-sensitivity model, we expected that stress 
would be associated in the moment with psychotic-like and paranoid, but not negative, 
symptoms. We specifically predicted that reports of the current situation being stressful, as well 
as reports of social stress, would predict psychotic-like and paranoid symptoms. Furthermore, we 
predicted that positive schizotypy would moderate these associations—that is, the association of 
stress and psychotic-like symptoms in the moment would only occur at high levels of positive 
schizotypy. Note that a concurrent association of stress and psychotic-like symptoms does not 
disentangle whether stress gives rise to these symptoms. Therefore, we predicted that stress at the 
preceding ESM signal would predict psychotic-like and paranoid symptoms at the current 
assessment, and that this would only occur at elevated levels of positive schizotypy. We did not 
expect that negative schizotypy would be associated with stress reactivity, given its trait-like 
nature and association with diminished affect. Note that the present study employed a nonclinical 
sample of young adults. Therefore, we expected that the overall levels of psychotic-like, 
paranoid, and negative symptoms in daily life would be relatively low, but would demonstrate 
predicted associations with psychometrically assessed positive and negative schizotypy. 
Method 
Participants 
The data were collected as part of an ongoing longitudinal project examining psychosis risk and 
expression. The participants were drawn from a screening sample of 589 undergraduates at the 
Universitat Autónoma de Barcelona, Spain. Usable screening data were obtained from 547 
participants (42 were excluded due to invalid protocols). A subset of 339 participants was invited 
to take part in the ESM assessment with the goal of assessing 200 individuals. We invited all 189 
who had standard scores based upon sample norms of at least 1.0 on the positive or negative 
schizotypy dimension, the suspiciousness subscale of the Schizotypal Personality Questionnaire 
(SPQ; Raine, 1991), or the positive-symptom subscale of the Community Assessment of Psychic 
Experiences (CAPE; Stefanis et al., 2002), and 150 randomly selected participants who had 
standard scores <1.0 on each of these measures. The goal of the enrichment procedure was to 
ensure adequate representation of schizotypy in the sample. Usable ESM data were collected 
from 206 participants (163 female) with a mean age of 19.8 ( SD = 2.4). An additional eight 
participants enrolled in the ESM study, but were omitted due to equipment malfunctions or 
insufficient ESM data. The final ESM sample included 48 participants (23.3%) with standard 
scores of at least 1.0 and 23 participants (11.2%) with standard scores of at least 2.0 on the 
positive schizotypy dimension. It included 52 participants (25.2%) with standard scores of at 
least 1.0 and 23 participants (11.2%) with standard scores of at least 2.0 on the negative 
schizotypy dimension. Ethical approval for the study was granted by the university ethics 
committee and participants provided informed consent. 
Materials and Procedures 
Participants completed Spanish versions of the WSS ( Ros-Morente, Rodríguez-Hansen, Vilagrà-
Ruiz, Kwapil, & Barrantes-Vidal, 2010). The scales reliably produce two factors, positive and 
negative schizotypy, that account for 80% of their variance. Participants were assigned positive 
and negative schizotypy factor scores based upon norms from 6,137 young adults ( Kwapil et al., 
2008). The mean score for the positive schizotypy dimension was −.31 ( SD = .89), with a range 
of −1.56 to 3.23. The mean for the negative schizotypy dimension was .02 ( SD = 1.05), with a 
range of −1.57 to 4.27. Both distributions were unimodal and positively skewed. Note 
that Kwapil, Ros-Morente et al. (2012) demonstrated that the positive and negative schizotypy 
factor structure underlying the WSS was invariant in Spanish and American samples (consistent 
with Fonseca-Pedrero, Paino, Lemos-Giráldez, Sierra-Baigrie, & Muñiz, 2010). Furthermore, 
these norm-based factor scores correlated .99 with factor scores generated from principal 
components analyses with the original Spanish screening sample of 547. 
ESM data were collected on personal digital assistants (PDAs). The ESM questionnaire inquired 
about a variety of daily life events. Table 1 contains the English translation of the ESM items and 
indices. In contrast to previous studies of schizotypy in daily life, the present study included 8 
items assessing psychotic-like symptoms, 2 items assessing paranoid symptoms, and 8 items 
assessing characteristics of negative schizotypic symptoms. Note that we created separate 
psychotic-like and paranoid symptom indices given that previous findings have suggested that 
these are separate dimensions of schizotypy (e.g., Stefanis et al., 2004). We did not create a 
negative symptom index because the items were not asked at every signal; however, these items 
are indicated in Table 1. The PDA signaled the participants to complete the questionnaire eight 
times daily between 10 a.m. and 10 p.m. for seven days.  
Table 1 Experience-Sampling Methodology Questionnaire and Summary Indices 
Note: all questions answered from 1 (not at all) to 7 (very much), unless otherwise noted 
1) Right now I feel happy 
2) Right now I feel sad 
3) Right now I feel anxious (nervous) 
4) Right now I fear losing control 
5) Right now I feel relaxed 
6) Right now I feel angry 
7) Right now I feel weird 
8) Right now I feel good about myself 
9) Right now I feel guilty or ashamed 
10) Right now I can concentrate well 
11) Right now I have difficulty controlling my thoughts 
12) Right now I have no thoughts or emotions 
13) Right now my thoughts are strange or unusual 
14) Right now I feel tired 
15) Right now I feel that others care about me 
16) Right now I feel suspicious 
17) Right now familiar things have a special meaning or importance to me 
18) Right now I do not feel well 
19) Right now I feel mistreated 
20) I like what I’m doing right now 
21) Right now I can do my current activity 
22) Right now my sight or hearing seem strange or unusual 
23) Since the last beep, I have heard or seen things others could not 
24) Right now I feel that someone or something is controlling my thoughts or actions 
25) Right now familiar things seem strange and unusual 
26) Right now I can cope 
27) My current situation is positive 
28) My current situation is stressful 
29) Since the last beep, I consumed: Food |Caffeine| Medication |Snuff | Alcohol | Cannabis or 
other drugs 
30) Right now I am alone Yes  1, No  2 
If answer is yes to item 30: 
31) I am alone because people do not want to be with me 
32) Right now I would prefer to be with people 
If answer is no to item 30: 
33) I feel close to this person (these people) 
34) Right now I would prefer to be alone 
Note. Negative affect index is the mean of Items 2, 3, 6, and 9 (coefficient α = .83). Paranoia 
index is the mean of Items 16 and 19 (coefficient α = .70). Psychotic-like experiences index is 
the mean of Items 4, 7, 11, 13, 22, 23, 24, and 25 (coefficient α = .74). Negative symptom items 
include: 1 (reversed), 8 (reversed), 12, 20 (reversed), 27 (reversed), 32 (reversed), 33 (reversed) 
and 34. 
ESM data have a hierarchical structure in which ESM ratings repeatedly made in daily life (level 
1 data) are nested within participants (level 2 data). Hierarchical linear modeling provides a more 
appropriate method than conventional unilevel analyses for analyzing nested data and is standard 
for the analysis of ESM data ( Luke, 2004; Nezlek, 2001). The multilevel analyses examined 
three types of relationships between the schizotypy factor scores and daily life experiences. The 
first type of analyses examined whether positive and negative schizotypy uniquely predicted 
experiences such as psychotic-like symptoms and negative affect in daily life. Specifically, these 
direct effects examined whether the schizotypy dimensions (level 2 predictors) predicted the 
intercept of the ESM ratings (level 1 dependent measures). The second type of analyses 
examined whether the associations of experiences in daily life (e.g., stress and psychotic-like 
symptoms) were moderated by the positive and negative schizotypy dimensions. These cross-
level interactions (or slopes-as-outcomes) tested whether the relationship of ESM ratings (level 1 
variables) within an individual is predicted by the schizotypy dimension scores (level 2 
variables). Cross-level interactions examined the association of level 1 predictors (e.g., stress) 
and level 1 criteria (e.g., psychotic-like symptoms) that were assessed at the same ESM 
questionnaire. Because the level 1 predictors and criteria are measured at the same ESM 
questionnaire, cross-level interactions did not allow us to disentangle temporal relationships 
between the level 1 predictors and criteria. The third type of analysis allowed us to examine the 
temporal sequence of experiences in daily life. Time-lagged analyses examined whether level 1 
predictors at the preceding ESM assessment predicted criteria at the current assessment, and 
whether this relationship varied across (was moderated by) positive and negative schizotypy. The 
level 2 predictors, positive and negative schizotypy, were entered simultaneously in all analyses. 
The analyses were computed with Mplus6 ( Muthén & Muthén, 2010). Level 1 predictors were 
group mean centered and level 2 predictors were grand mean centered. The data departed from 
normality in some cases, so parameter estimates were calculated using robust standard errors. 
Furthermore, level 1 criteria exhibiting substantial skew were treated as categorical. 
Note that ESM studies involve complex designs in which constructs are measured at multiple 
levels (in the lab and in daily life). We used the terms positive and negative schizotypy 
dimensions to refer to the level 2 variables based upon WSS factor scores. We assessed a variety 
of schizotypic symptoms in daily life including psychotic-like, paranoid, and negative symptoms. 
We used the term “symptoms” rather than “experiences”; however, we realize that these are 
assessed in a nonclinical sample and involve both clinical and subclinical manifestations. 
Obviously, the ESM questions are not diagnostic and we know from other studies of this sample 
(e.g., Barrantes-Vidal, Gross et al., 2013) that the majority of participants do not meet criteria for 
schizophrenia-spectrum disorders at the present time. However, consistent with our conceptual 
model of schizotypy, we expect that the positive and negative schizotypy dimensions will be 
associated with schizotypic or schizophrenic-like symptoms and experiences in daily life. 
Results 
Participants completed an average of 40.8 usable questionnaires ( SD = 9.1). Neither the positive 
nor the negative schizotypy factor was associated with the number of usable records ( r = .00 and 
.03, respectively). The positive and negative schizotypy dimension scores were not significantly 
correlated ( r = .11). 
Associations of Positive and Negative Schizotypy With Experiences in Daily Life 
Positive and negative schizotypy were differentiated by participants’ experiences of affect and 
functioning in daily life (see Table 2). Positive schizotypy was associated with diminished 
positive and increased negative affect (as well as with each individual negative affect rating). 
Likewise, it was associated with decreased reports of the current situation as positive and 
increased reports that the situation was stressful. Positive schizotypy was associated with 
impaired ability to concentrate and diminished feelings of being able to cope in the moment. As 
expected, negative schizotypy was associated with the four negative-symptom items assessing 
diminished positive affect and situations, and decreased enjoyment of current activities, but was 
unassociated with ratings of negative affect and stress. Neither positive nor negative schizotypy 
was associated with reports of drug use in daily life.  
 
Table 2 Relationship of Positive and Negative Schizotypy with Affect and Functioning in Daily 
Life 
Level 1 criterion  Level 2 predictors 
 Positive schizotypy γ01 (df = 
203)  
Negative schizotypy  γ02 (df = 
203) 
Happy -0.265 (0.070)***  -0.178 (0.049)*** 
Good about self -0.294 (0.064)***  -0.214 (0.053)*** 
Negative affect  0.229 (0.050)***   0.048 (0.038) 
Situation positive -0.321 (0.070)***  -0.237 (0.055)*** 
Situation stressful  0.297 (0.078)***   0.081 (0.068) 
Enjoy current activity -0.108 (0.060) -0.186 (0.047)*** 
Able to cope -0.285 (0.058)***  -0.156 (0.052)** 
Able to concentrate  -0.252 (0.071)***  -0.042 (0.064) 
Drug use  -0.276 (0.641)  -0.443 (0.544) 
Note. Raw multilevel regression coefficients indicating the relationship of the level 2 predictors 
with the level 1 (daily life experience) criteria. * p < .05. ** p < .01. *** p < .001. 
The schizotypy dimensions were associated with psychotic-like and suspicious symptoms, and 
with the negative symptom of diminished thoughts and emotions in daily life (see Table 3). 
Positive schizotypy was associated with all of the items tapping psychotic-like symptoms, such 
as difficulty controlling one’s thoughts and hearing/seeing things that others could not sense, as 
well as with feeling suspicious and mistreated in the moment. As expected, negative, but not 
positive, schizotypy predicted having no thoughts or emotions. However, negative schizotypy 
also predicted the psychotic-like and paranoia indices, as well as several of the individual 
symptoms comprising those composites.  
 
Table 3 Relationship of Positive and Negative Schizotypy with Psychotic-Like, Paranoid, and 
Negative Schizotypic Experiences in Daily Life 
Level 1 criterion Level 2 predictors 
 Positive schizotypy γ01 (df = 
203)  
 Negative schizotypy γ02 (df = 
203) 
Fear losing control  0.510 (0.128)***  0.175 (0.132) 
Feel weird  0.891 (0.135)***  0.244 (0.112)* 
Difficulty controlling thoughts  0.702 (0.124)***  0.225 (0.113)* 
Strange or unusual thoughts  0.664 (0.142)***  0.343 (0.117)** 
Special meaning  0.988 (0.219)***  -0.335 (0.186) 
Senses are Unusual  0.368 (0.146)**  0.308 (0.094)*** 
Hearing/seeing things  0.385 (0.158)*  0.077 (0.144) 
Feel controlled  0.415 (0.151)**  0.196 (0.117) 
Familiar things strange  0.765 (0.146)***  0.369 (0.109)** 
Psychotic-like experience 
index  
0.066 (0.014)***  0.025 (0.009)** 
Feel suspicious  0.760 (0.140)***  0.308 (0.115)** 
Feel mistreated  0.579 (0.153)***  0.191 (0.124) 
Paranoia index  0.126 (0.031)***  0.054 (0.023)* 
No thoughts or emotions  -0.015 (0.035)  0.244 (0.059)*** 
Note. Raw multilevel regression coefficients indicating the relationship of the Level-2 predictors 
with the Level-1 (daily life experience) criteria. * p < .05. ** p < .01. *** p < .001. 
A possible concern with interpreting these results is that the ESM psychotic-like symptom items 
may generally be capturing emotional distress rather than specifically tapping psychotic-like 
symptoms, and that the association of positive schizotypy with the psychotic-like symptoms in 
daily life may reflect the association of positive schizotypy with increased general distress. It is 
possible that the subtle or psychotic-like wording of the items (e.g., “right now I fear losing 
control”) may be more likely to capture variance associated with general distress than items 
assessing frank psychosis. Furthermore, items assessing psychotic-like or psychotic experiences 
likely capture variance associated with distress related to the experience. However, we believe 
that two lines of evidence suggest that our psychotic-like ESM items are not primarily capturing 
variance associated with emotional distress, and that their association with positive schizotypy is 
not simply driven by emotional distress. First of all, the endorsement rates for the ESM stress 
and negative affect items are generally higher than for the psychotic-like symptom items, 
suggesting that the latter were not simply tapping general distress. Furthermore, we recomputed 
the analyses predicting ESM psychotic-like and paranoid symptom ratings after partialing 
out Symptom Checklist-90–Revised ( SCL-90–R; Derogatis, 1994) anxiety-subscale scores (our 
closest proxy measure for general distress). In both cases, positive schizotypy predicted 
psychotic-like symptoms in daily life, over and above the effects of general distress. 
Both schizotypy dimensions were associated with decreased social contact and diminished 
reports that others cared about them (see Table 4). Consistent with Kwapil, Brown et al. (2012), 
negative schizotypy was associated with negative-symptom items of diminished closeness, 
increased preference to be alone when with others, and decreased desire to be with others when 
alone. Positive schizotypy was associated with increased desire to be alone when with others.  
 
Table 4 Relationship of Positive and Negative Schizotypy with Social Contact and Functioning 
in Daily Life 
Level 1 criterion Level 2 predictors 
 Positive schizotypy γ01 (df = 
203) 
Negative schizotypy γ02 (df = 
203) 
Others care about me  -0.233 (0.077)**  -0.381 (0.083)*** 
Alone at signala  -0.171 (0.053)**  -0.138 (0.044)** 
When with others 
Close to other  -0.105 (0.066)  -0.253 (0.063)*** 
Prefer to be alone  0.221 (0.052)***  0.220 (0.047)*** 
When alone 
Alone b/c not wanted  0.354 (0.210)  0.211 (0.209) 
Prefer to be with others -0.033 (0.095)  -0.208 (0.084)*** 
Note. Raw multilevel regression coefficients indicating the relationship of the level 2 predictors 
with the level 1 (daily life experience) criteria. a Item is scored alone = 1 and with others = 2. * p 
< .05. ** p < .01. *** p < .001. 
Association of Stress and Schizotypic Symptoms 
We next examined whether stress was associated with psychotic-like and paranoid symptoms, 
and with the negative symptom of diminished thoughts and emotions in the moment, and 
whether these relationships varied across levels of positive and negative schizotypy (see Table 
5). Specifically, we examined whether schizotypic symptoms were associated with reports that 
the current situation was stressful and with two indicators of social stress, “Being with people 
with whom you are not close” and “Feeling unwanted.” We also used the dichotomous item 
“Alone/with others” as a Level-1 predictor to differentiate the effects of social contact from 
social stress. As hypothesized, stressful situations and social stress (but not social contact) were 
associated with psychotic-like and paranoid symptoms in the moment, but were not associated 
with the negative symptom of diminished thoughts or emotion. Stress was associated with 
psychotic-like and paranoid symptoms—and in every case, this relationship was moderated by 
positive schizotypy. As seen in Figure 1, stress was associated with psychotic-like and paranoid 
symptoms, but only in participants high in positive schizotypy. Similarly, Figure 2 displays that 
social stress was associated with psychotic-like symptoms, but only in high positive schizotypy 
participants. In contrast to our hypotheses, negative schizotypy moderated the association of 
social closeness and feeling unwanted with psychotic-like symptoms in the moment.  
Table 5 Cross-Level Interactions of Stress and Schizotypic Symptoms Across Levels of Positive 
and Negative Schizotypy 
Level 1 criterion Level 1 predictor Level 2 predictors@ 
 γ10 (df = 203)  Positive 
schizotypy γ11 (df 
= 203) 
 Negative 
schizotypy γ12 (df 
= 203) 
Psychotic-like 
index 
 Situation 
stressful 
0.034 (0.004)***  0.018 (0.006)**  0.007 (0.004) 
Psychotic-like 
index 
 Alone  0.000 (0.006)  -0.013 (0.008)  -0.001 (0.005) 
Psychotic-like 
index 
 Close to other -0.008 (0.003)**  -0.009 (0.003)**  -0.005 (0.002)* 
Psychotic-like 
index 
 Alone b/c not 
wanted  
0.069 (0.014)***  0.053 (0.018)**  0.051 (0.018)** 
Paranoia index  Situation 
stressful  
0.077 (0.009)***  0.027 (0.012)* 0.004 (0.009) 
Paranoia index  Alone -0.007 (0.014)  -0.016 (0.017)  0.017 (0.013) 
Paranoia index  Close to other -0.028 
(0.007)*** 
-0.028 (0.009)** -0.014 (0.007) 
Paranoia index  Alone b/c not 
wanted 
0.136 (0.046)**  0.092 (0.045)*  0.068 (0.062) 
No thoughts or 
emotions 
 Situation 
stressful 
-0.004 (0.007) 0.005 (0.007) -0.007 (0.007) 
No thoughts or 
emotions 
 Alone  -0.021 (0.019)  -0.011 (0.018)  -0.023 (0.020) 
No thoughts or 
emotions 
 Close to other  -0.023 (0.009)** -0.007 (0.007) -0.016 (0.010) 
No thoughts or 
emotions 
 Alone b/c not 
wanted 
0.022 (0.043)  -0.010 (0.021)  0.027 (0.039) 
@ Cross-level interaction of the association of the Level-2 variable with the slope of the Level-1 
predictor and criterion. *p < .05. ** p < .01. *** p < .001. 
 
Figure 1. Cross-level interactions of stress with psychotic-like and paranoid experiences across 
levels of positive schizotypy. 
 
 
Figure 2. Cross-level interactions of social stress with psychotic-like experiences across levels of 
positive schizotypy. 
In order to disentangle the temporal sequence of stress with psychotic-like and paranoid 
symptoms, we conducted time-lagged analyses examining whether stress at the preceding ESM 
signal predicted psychotic-like and paranoid symptoms at the current ESM signal, and whether 
schizotypy moderated these relationships. We also reversed the association examining whether 
symptoms at the preceding signal predicted stress at the current signal. Note that we did not 
conduct these analyses for the social predictors, because the ESM social closeness item was only 
answered when participants were with others and the ESM unwanted item was only answered 
when participants were alone—raising concerns that there were not sufficient numbers of 
contiguous questions completed for these items to allow for time-lagged analyses. As can be 
seen in Table 6, stress at the preceding ESM signal predicted psychotic-like symptoms and this 
association was moderated by positive schizotypy. Furthermore, this effect held even after 
partialing out the effects of psychotic-like symptoms at the previous signal—that is, the 
significant association of prior stress with current psychotic-like associations at high levels of 
positive schizotypy was not simply the result of psychotic-like symptoms at the prior signal (γ 11 
= 0.007, SE = 0.004, p < .05). Note that stress also predicted the development of paranoid 
symptoms, and both psychotic-like and paranoid symptoms were associated with stress at the 
subsequent signal, but none of these relations was moderated by positive schizotypy.  
 
Table 6 Time-Lagged Analyses of Stress and Schizotypic Symptoms Across Levels of Positive 
and Negative Schizotypy 
Level 1 criterion Level 1 predictor (preceding 
signal) 
Level 2 predictors@ 
 γ10 (df = 203) Positive 
schizotypy γ11 (df 
= 203) 
 Negative 
schizotypy γ12 (df 
= 203) 
Psychotic-like 
index  
Situation 
stressful  
0.014 (0.003)***  0.013 (0.004)**  -0.001 (0.003) 
Situation 
stressful  
Psychotic-like 
index  
0.362 (0.122)**  0.050 (0.090)  -0.061 (0.092) 
Paranoia index  Situation 
stressful  
0.040 (0.010)***  0.011 (0.012)  0.003 (0.008) 
Situation 
stressful  
Paranoia index  0.211 (0.058)*** -0.015 (0.046)  -0.034 (0.042) 
@ Time-lagged interaction of the association of the Level 2 variable with the slope of the Level 1 
predictor and criterion. * p < .05. ** p < .01. *** p < .001. 
Note that five of the 206 participants met criteria for schizophrenia-spectrum Cluster A 
personality disorders of the Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text 
rev. ( DSM–IV–TR; APA, 2000). These included three participants with paranoid personality 
disorder, one with schizotypal personality disorder, and one with both schizotypal and paranoid 
personality disorders. Following the recommendations of a reviewer, we reran all of the direct-
effect and cross-level analyses with these participants omitted. The statistical significance was 
unchanged for all of the analyses, other than for two direct effects and one cross-level 
interaction. Specifically, positive schizotypy’s association was no longer significant for the ESM 
items “Senses are unusual” and “Hearing/seeing things.” Furthermore, positive schizotypy no 
longer predicted the cross-level interaction of situation stressful and the paranoia index. Note that 
following the recommendation of a reviewer, we also examined the association of reports of drug 
use in daily life with psychotic-like and paranoid symptoms. Neither of these relationships were 
significant, nor were the cross-level interactions of these relationships with positive and negative 
schizotypy. 
Discussion 
The present study examined the real-world expression of positive and negative schizotypy in a 
nonclinically ascertained Spanish sample of young adults. Our findings lend further support to a 
growing body of research supporting the multidimensional structure of schizotypy (e.g., Kwapil 
et al., 2008; Kwapil, Brown et al., 2012). Positive and negative schizotypy are promising 
dimensions in that they can be readily identified in nonclinical samples and exhibit differential 
patterns of associations, both in the laboratory and in daily life. The present study revealed that 
positive and negative schizotypy were differentially expressed in daily life in terms of affect, 
schizotypic symptoms, social contact, social functioning, and stress reactivity. The heterogeneity 
of schizotypy and schizophrenia-spectrum disorders (e.g., Liddle, 1987; Vollema & van den 
Bosch, 1995) highlights the need for these dimensions to be differentiated when conducting 
research. The present findings also supported the cross-cultural validity of schizotypy. In 
addition, the study supported the utility of psychometric screening for identifying at-risk 
individuals in nonclinical samples. Although psychotic-like symptoms were endorsed at a 
relatively low rate, they reflectd the same pattern of expression found in schizophrenia. 
Moreover, these psychotic-like, paranoid, and negative symptoms were associated, as 
hypothesized, with positive and negative schizotypy dimensions. The present findings are 
consistent with community studies (e.g., Van Os, Hanssen, Bijl, & Ravelli, 2000), family studies 
(e.g., Kendler, McGuire, Gruenberg, & Walsh, 1995), studies of the prodrome (e.g., Woods et 
al., 2009), and high-risk designs (e.g., Gooding, Tallent, & Matts, 2005), which indicate that 
brief, transient, and subclinical psychotic symptoms are not uncommon in the general population 
and may precede the development of schizophrenia-spectrum disorders. 
The present study presented an extensive examination of the momentary experience of 
psychotic-like, paranoid, and negative symptoms. Based upon a review of the ESM literature, we 
believe that a strength of this study is that we assessed a larger number and a broader range of 
psychotic-like experiences in daily life than have previous studies. Our previous study of the 
expression of positive and negative schizotypy in daily life ( Kwapil et al., 2012) primarily 
examined the experience of affect and social functioning, and did not include ESM items 
assessing psychotic-like experiences. The present study focused on examining schizotypic 
symptoms in daily life. Given that there is a practical limitation on the number of ESM questions 
that can be assessed at each signal, we were not able to include as many items examining affect, 
social functioning, and activities in this study as in our previous study. Note that we are currently 
conducting studies to expand our assessment of the association of the schizotypy dimensions 
with cognitive impairment in daily life. 
Note that unlike the overall index that we computed for the psychotic-like symptoms in daily 
life, we did not compute an overall index for negative symptoms. Negative symptoms do not 
have a universally accepted definition, but usually include flattened affect, anhedonia, social 
disinterest, avolition, anergia, and alogia. We believe that at least eight items tapped this 
construct, including: “Right now I have no thoughts or emotions,” “Right now I feel happy 
(reversed),” “Right now I feel good about myself (reversed),” “My current situation is positive 
(reversed),” “Right now I would prefer to be with people (asked when alone and reversed),” 
“Right now I would prefer to be alone (asked when with others),” “I feel close to this 
person/these people” (asked when with others and reversed), and “I like what I’m doing right 
now (reversed).” It is worth noting that negative schizotypy was significantly associated with 
each of these items in the expected direction. 
The present findings indicated that positive schizotypy was uniquely associated with the 
paranoid symptom of feeling mistreated, whereas individuals with both positive and negative 
schizotypy reported increased levels of suspiciousness. We suggest that suspiciousness conveys a 
more moderate questioning of the trustworthiness of situations and others, whereas feeling 
mistreated reflects a more active experience. As hypothesized, positive schizotypy was 
associated with the psychotic-like symptoms index score and each of the individual symptoms. 
These included psychotic-like disruptions in cognition, passivity experiences, and unusual 
perceptual experiences. Negative schizotypy was related to overall psychotic-like symptoms and 
several of the individual symptoms. Specifically, negative schizotypy was associated with 
psychotic-like symptoms involving cognitive disruptions (e.g., difficulty controlling thoughts), 
but not symptoms involving strong affective responses (e.g., fear of losing control). This is 
consistent with findings that negative schizotypy is associated with diminution of thought and 
affect, analogous to alogia and affective flattening observed in negative symptoms in 
schizophrenia. 
The finding that negative schizotypy was associated with some psychotic-like and paranoid 
symptoms is consistent with historical notions dating back to Bleuler (1911/1950), that negative 
symptoms represent the fundamental symptoms of schizophrenia and embody the core genetic 
construct of schizophrenia ( Torgersen et al., 2002). Furthermore, negative schizotypy in 
nonclinical samples is associated with the development of schizophrenia-spectrum disorders 
( Kwapil et al., 2013) and social anhedonia and withdrawal were associated with positive 
symptoms in schizophrenia patients and in unaffected siblings ( Velthorst et al., 
2012). Dominguez et al. (2010) proposed a model in which negative symptoms reflect deviances 
in brain development related to genetic risk that influence a final common pathway of 
neurotransmitter dysregulation that, in interaction with environmental exposures, results in the 
emergence of positive symptoms. Findings from their longitudinal study supported two separate 
liabilities, reality distortion and developmental impairment, that map onto positive and negative 
symptoms, respectively. Of note, persistent negative features preceded positive features. 
The fundamental differences in positive and negative symptoms raise potential concerns that our 
assessments of these symptoms in daily life were not comparable. Positive symptoms represent 
deviant expressions of affect, cognition, and perception (e.g., odd beliefs or perceptual 
experiences), whereas negative symptoms often involve diminution of normal aspects of 
functioning (e.g., affect, cognition, and social functioning). Oorschot et al. (2009) reviewed 
studies of negative symptoms in daily life and stated that negative symptoms should be assessed 
in terms of [diminished] mood and interest in daily life. Our psychotic-like symptom items 
generally assessed odd and unusual experiences. In contrast, only one of the negative-symptom 
items (no thoughts or emotions) assessed a markedly unusual experience. The remainder of the 
negative-symptom items assessed appraisals of affect, cognition, and social functioning. Note 
that this is consistent with previous studies of negative symptoms in daily life (e.g., Oorschot et 
al., 2013). Obviously, experiences other than negative schizotypy (e.g., depression) could predict 
these experiences. However, our previous findings (e.g., Kwapil et al., 2008; Barrantes-Vidal et 
al., 2013) indicated that negative schizotypy is not associated with depression and the current 
results indicated that negative schizotypy was not associated with negative affect. An additional 
measurement concern was that all of our psychotic-like and paranoid items were administered at 
every questionnaire, whereas only seven of the eight negative-symptom items were administered 
at every questionnaire (one item was only administered when the participant was with others and 
one was only administered when he or she was alone). Thus, we were unable to compute an 
overall negative-symptom index. Therefore, additional refinements are needed for the assessment 
of negative symptoms in daily life. 
In addition to the direct associations of positive and negative schizotypy in daily life, we also 
examined whether the relation of schizotypic symptoms to specific stressors was exacerbated in 
individuals with high schizotypy scores, indicating a particular vulnerability to stress. Indeed, we 
found that stressful situations and social stress are associated with momentary psychotic-like and 
paranoid symptoms for those high in positive schizotypy, but not those low in positive 
schizotypy. Stress may precipitate impairment, distress, and even some psychological symptoms 
in people low in positive schizotypy, but we would argue that it would be relatively unlikely to 
produce psychotic-like symptoms in such individuals. In contrast, social contact was unrelated to 
the experience of psychotic-like and paranoid symptoms, highlighting the critical importance of 
subjective appraisals of social experiences. 
Unexpectedly, negative schizotypy predicted the association of social stress with momentary 
psychotic-like symptoms. However, it did not moderate the association of psychotic-like 
symptoms with nonsocial, situational stress. This is consistent with the finding that negative 
schizotypy is associated with feeling uncared for, a sense of social distance, and the preference to 
be alone when with others, but not with negative affect or perceiving situations as stressful. In 
other words, negative schizotypy moderates psychotic reactivity to socially defeating appraisals, 
but not to general stress. Given the lack of comparable studies, these findings require replication, 
but highlight the utility of ESM for teasing apart dynamic relationships of affect, cognition, and 
symptoms. These findings support the need to deepen our understanding of the psychological 
architecture of negative symptoms, which has received limited attention relative to positive 
symptoms (e.g., Rector, Beck, & Stolar, 2005). Furthermore, even though negative schizotypy 
acted as a moderator, these stressors were related to the experience of transient psychotic-like 
symptoms only, and not to trait-like negative symptoms of having no thoughts or emotions. This 
reveals an exclusive pattern of stress sensitivity for individuals with positive symptoms. 
We also examined the temporal sequence of psychotic-like experiences in daily life for this 
study. Specifically, we found that daily life stressors (including social stress) were associated 
with the simultaneous experience of psychotic-like and paranoid symptoms for individuals high 
in positive schizotypy (and in some cases negative schizotypy). Furthermore, the experience of 
stress preceded the onset of psychotic-like symptoms for those with high positive schizotypy 
scores. Several features of these findings are worth noting. First of all, the time-lagged 
association of stress with psychotic-like experiences was unique to high positive schizotypy, 
whereas the association of paranoid symptoms was not unique to positive schizotypy (although 
the main effect was elevated in high positive schizotypy). This suggests that stress only produces 
the deviant psychotic-like experiences in positive schizotypic individuals, whereas stress can 
produce suspiciousness and feelings of mistreatment in nonschizotypic individuals (albeit to a 
greater extent in positive schizotypy). Second, the time-lagged effect of stress at the previous 
signal producing psychotic-like symptoms was over and above the effects of psychotic-like 
symptoms at the previous signal—so it was not simply the case of psychotic-like symptoms 
predicting more symptoms across time. We were not surprised to find that the experience of 
psychotic-like symptoms at the preceding signal produced stress at the subsequent signal, nor 
that this was not unique to positive schizotypy, but the association of preceding stress with 
psychotic-like symptoms was unique to high positive schizotypy. In other words, anyone who 
experienced psychotic-like symptoms would subsequently tend to report increased stress, but 
stress only predicted the development of psychotic-like symptoms in high positive schizotypy 
individuals. As seen by these examples, ESM provides a unique method for examining these 
complex temporal associations. Understanding the temporal sequence of the experience of such 
symptoms should help to identify causal pathways and may provide useful translational 
implications. Obviously, the present study was limited by the fact that we were examining a 
nonclinically ascertained sample; however, we are currently extending our findings by 
examining the temporal sequence of psychotic-like symptoms in prodromal and first-episode 
psychotic patients. 
The finding that stress predicted the onset of psychotic-like symptoms in individuals with high 
levels of positive schizotypy is especially problematic, given that these individuals reported more 
stress than their nonschizotypic peers. According to Nuechterlein and Dawson’s 
(1984) vulnerability–stress model, both stressful life events and momentary hassles may serve as 
precipitating factors for psychotic episodes in at-risk individuals. Furthermore, psychotic-like 
symptoms in nonpsychotic schizotypes predict the development of psychotic disorders. For 
example, a longitudinal study showed that 14% of schizotypic individuals with psychotic-like 
experiences in early adulthood developed a psychotic disorder 10 years later ( Chapman et al., 
1994; Kwapil, Chapman, & Chapman, 1999). Therefore, the measurement of psychotic-like 
symptoms in the moment may identify individuals at risk for developing psychosis. 
The present findings provide clues regarding possible risk and protective factors for the 
experience of psychotic-like experiences in the moment. As depicted in Figure 2, participants 
who were with people they felt close to experienced fewer psychotic-like symptoms in the 
moment. This relationship holds true even for individuals with high levels of schizotypy. So 
spending time with close friends and family appears to protect at-risk individuals from 
experiencing momentary symptoms and may act as a long-term buffer against the development 
of schizophrenia-spectrum disorders. As continued ESM research points to additional protective 
factors, interventions with better ecological validity can be developed. An in-the-moment clinical 
assessment tool, the PsyMate ( Myin-Germeys, Birchwood, & Kwapil, 2011), has recently been 
used to help patients assess the frequency, intensity, and duration of their psychotic symptoms. 
Researchers found that both internal (e.g., stress, diminished self-esteem) and external factors 
(e.g., urban exposure, social context, cannabis) precede paranoia and positive symptoms in these 
patients. This method offers a promising intervention strategy that could involve providing daily 
cognitive–behavioral therapy feedback ( Myin-Germeys et al., 2011). These techniques could be 
employed with nondisordered schizotypes to minimize daily stress and the onset of psychotic-
like symptoms, as well as to increase their quality of life by ameliorating affective, social, and 
functioning problems they experience in day-to-day life. 
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